Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
AFJKU
Upturn stock ratingUpturn stock rating

Aimei Health Technology Co., Ltd Unit (AFJKU)

Upturn stock ratingUpturn stock rating
$11.25
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: AFJKU (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $0

1 Year Target Price $0

Analysts Price Target For last 52 week
$0Target price
Low$
Current$11.25
high$

Analysis of Past Performance

Type Stock
Historic Profit -0.44%
Avg. Invested days 27
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta -
52 Weeks Range 10.51 - 12.90
Updated Date 06/5/2025
52 Weeks Range 10.51 - 12.90
Updated Date 06/5/2025
Dividends yield (FY) -
Basic EPS (TTM) -

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -0.92%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 69617552
Price to Sales(TTM) -
Enterprise Value 69617552
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 3988921
Shares Outstanding -
Shares Floating 3988921
Percent Insiders 5.53
Percent Institutions 0.04

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Aimei Health Technology Co., Ltd Unit

stock logo

Company Overview

overview logo History and Background

Aimei Health Technology Co., Ltd Unit is not a publicly traded US company. Therefore, detailed information about its founding year, milestones, and evolution is unavailable in standard US stock market data sources.

business area logo Core Business Areas

  • Segment Name 1: Information unavailable due to the company not being publicly traded on the US stock market.

leadership logo Leadership and Structure

Information unavailable due to the company not being publicly traded on the US stock market.

Top Products and Market Share

overview logo Key Offerings

  • Product Name 1: Information unavailable due to the company not being publicly traded on the US stock market.

Market Dynamics

industry overview logo Industry Overview

Information unavailable due to the company not being publicly traded on the US stock market.

Positioning

Information unavailable due to the company not being publicly traded on the US stock market.

Total Addressable Market (TAM)

Information unavailable due to the company not being publicly traded on the US stock market.

Upturn SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Competitors and Market Share

competitor logo Key Competitors

Competitive Landscape

Information unavailable due to the company not being publicly traded on the US stock market.

Growth Trajectory and Initiatives

Historical Growth: Information unavailable due to the company not being publicly traded on the US stock market.

Future Projections: Information unavailable due to the company not being publicly traded on the US stock market.

Recent Initiatives: Information unavailable due to the company not being publicly traded on the US stock market.

Summary

Aimei Health Technology Co., Ltd Unit is not a publicly traded US company, so comprehensive financial data and competitive analysis are unavailable. Consequently, evaluating its strength, weaknesses, and market position is not feasible using standard US stock market resources. Further information from private sources would be required for a thorough assessment. The company may not have competitors or comparable structures that are publicly traded. Further research is needed to analyze its performance and potential.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Publicly available information about US stock market companies.

Disclaimers:

The information provided is based on the understanding that Aimei Health Technology Co., Ltd Unit is not a publicly traded US company. Analysis is limited by the lack of available data. This analysis is not a substitute for professional financial advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Aimei Health Technology Co., Ltd Unit

Exchange NASDAQ
Headquaters New York, NY, United States
IPO Launch date 2023-12-04
CEO, Secretary & Director Mr. Junheng Xie
Sector Financial Services
Industry Shell Companies
Full time employees -
Website
Full time employees -
Website

Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.